Screening of a genome-reduced Corynebacterium glutamicum strain library for improved heterologous cutinase secretion
- The construction of microbial platform organisms by means of genome reduction is an ongoing topic in biotechnology. In this study, we investigated whether the deletion of single or multiple gene clusters has a positive effect on the secretion of cutinase from Fusarium solani pisi in the industrial workhorse Corynebacterium glutamicum.
- A total of 22 genome-reduced strain variants were compared applying two Sec signal peptides from Bacillus subtilis. High-throughput phenotyping using robotics-integrated microbioreactor technology with automated harvesting revealed distinct cutinase secretion performance for a specific combination of signal peptide and genomic deletions.
- The biomass-specific cutinase yield for strain GRS41_51_NprE was increased by ~ 200%, although the growth rate was reduced by ~ 60%. Importantly, the causative deletions of genomic clusters cg2801-cg2828 and rrnC-cg3298 could not have been inferred a priori. Strikingly, bioreactor fed-batch cultivations at controlled growth rates resulted in a complete reversal of the screening results, with the cutinase yield for strain GRS41_51_NprE dropping by ~ 25% compared to the reference strain.
- Thus, the choice of bioprocess conditions may turn a ‘high-performance’ strain from batch screening into a ‘low-performance’ strain in fed-batch cultivation. In conclusion, future studies are needed in order to understand metabolic adaptations of C. glutamicum to both genomic deletions and different bioprocess conditions.
musagenomics
 Recombinant Human rhinovirus 1A Genome polyprotein, partial |
|||
| CSB-YP326367HQA | Cusabio | 6222 mg | Ask for price |
 Recombinant Human rhinovirus 1A Genome polyprotein,partial |
|||
| AP72911 | SAB | each | Ask for price |
|
|||
Recombinant Human rhinovirus 1A Genome polyprotein, partial |
|||
| CSB-EP326367HQA | Cusabio | 11613 mg | Ask for price |
Recombinant Human rhinovirus 1A Genome polyprotein, partial |
|||
| MBS1220686-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 375 |
Recombinant Human rhinovirus 1A Genome polyprotein, partial |
|||
| MBS1220686-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 275 |
Recombinant Human rhinovirus 1A Genome polyprotein, partial |
|||
| MBS1220686-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 640 |
Recombinant Human rhinovirus 1A Genome polyprotein, partial |
|||
| MBS1220686-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 450 |
Recombinant Human rhinovirus 1A Genome polyprotein, partial |
|||
| MBS1220686-05mgYeast | MyBiosource | 0.5mg(Yeast) | EUR 1065 |
Recombinant Human rhinovirus 1A Genome polyprotein,partial |
|||
| RPC25135-100ug | Biomatik Corporation | 100ug | EUR 573.1 |
Recombinant Human rhinovirus 1A Genome polyprotein,partial |
|||
| RPC25135-20ug | Biomatik Corporation | 20ug | EUR 288.8 |
 Recombinant Human rhinovirus 14 Genome polyprotein |
|||
| MBS1158398-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1205 |
Recombinant Human rhinovirus 14 Genome polyprotein |
|||
| MBS1158398-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 860 |
Recombinant Human rhinovirus 14 Genome polyprotein |
|||
| MBS1158398-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 995 |
Recombinant Human rhinovirus 14 Genome polyprotein |
|||
| MBS1158398-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1035 |
Recombinant Human rhinovirus 14 Genome polyprotein |
|||
| MBS1158398-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1135 |
 Recombinant Human rhinovirus 2 Genome polyprotein |
|||
| MBS1030888-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1205 |
Recombinant Human rhinovirus 2 Genome polyprotein |
|||
| MBS1030888-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 860 |
Recombinant Human rhinovirus 2 Genome polyprotein |
|||
| MBS1030888-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 995 |
Recombinant Human rhinovirus 2 Genome polyprotein |
|||
| MBS1030888-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1030 |
Recombinant Human rhinovirus 2 Genome polyprotein |
|||
| MBS1030888-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1135 |
 Recombinant Human rhinovirus 1B Genome polyprotein |
|||
| MBS1154102-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1205 |
Recombinant Human rhinovirus 1B Genome polyprotein |
|||
| MBS1154102-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 855 |
Recombinant Human rhinovirus 1B Genome polyprotein |
|||
| MBS1154102-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 995 |
Recombinant Human rhinovirus 1B Genome polyprotein |
|||
| MBS1154102-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1030 |
Recombinant Human rhinovirus 1B Genome polyprotein |
|||
| MBS1154102-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1130 |
 Recombinant Human rhinovirus 3 Genome polyprotein |
|||
| MBS1326793-005mgBaculovirus | MyBiosource | 0.05mg(Baculovirus) | EUR 1125 |
Recombinant Human rhinovirus 3 Genome polyprotein |
|||
| MBS1326793-005mgEColi | MyBiosource | 0.05mg(E-Coli) | EUR 860 |
Recombinant Human rhinovirus 3 Genome polyprotein |
|||
| MBS1326793-005mgYeast | MyBiosource | 0.05mg(Yeast) | EUR 995 |
Recombinant Human rhinovirus 3 Genome polyprotein |
|||
| MBS1326793-02mgEColi | MyBiosource | 0.2mg(E-Coli) | EUR 1120 |
Recombinant Human rhinovirus 3 Genome polyprotein |
|||
| MBS1326793-05mgEColi | MyBiosource | 0.5mg(E-Coli) | EUR 1225 |
 Recombinant Human rhinovirus 16 Genome polyprotein |
|||
| MBS1325019-005mgBaculovirus | MyBiosource | 0.05mg(Baculovirus) | EUR 1120 |
Recombinant Human rhinovirus 16 Genome polyprotein |
|||
| MBS1325019-005mgEColi | MyBiosource | 0.05mg(E-Coli) | EUR 860 |
Recombinant Human rhinovirus 16 Genome polyprotein |
|||
| MBS1325019-005mgYeast | MyBiosource | 0.05mg(Yeast) | EUR 995 |
Recombinant Human rhinovirus 16 Genome polyprotein |
|||
| MBS1325019-02mgEColi | MyBiosource | 0.2mg(E-Coli) | EUR 1120 |
Recombinant Human rhinovirus 16 Genome polyprotein |
|||
| MBS1325019-05mgEColi | MyBiosource | 0.5mg(E-Coli) | EUR 1225 |
 [His]) Recombinant Human Rhinovirus 16 VP3 (a.a. 331-562) [His] |
|||
| DAG-WT1151 | Creative Diagnostics | 1 mg | EUR 2000 |
|
|||
|
Description: Recombinant |
|||
 [His]) Recombinant Human Rhinovirus 16 VP4 (a.a. 2-69) [His] |
|||
| DAG-WT1152 | Creative Diagnostics | 1 mg | EUR 2000 |
|
|||
|
Description: Recombinant |
|||
 Human rhinovirus 1A Genome polyprotein |
|||
| 1-CSB-YP326367HQA | Cusabio |
|
|
|
|||
|
Description: Recombinant Human rhinovirus 1A Genome polyprotein,partial expressed in Yeast |
|||
 Recombinant Human rhinovirus 1B Genome polyprotein, partial |
|||
| CSB-EP320160HQB | Cusabio | 10401 mg | Ask for price |
) CD54, Recombinant, Human (ICAM-1, Intercellular Adhesion Molecule1, Human rhinovirus receptor, Precursor, BB2, Major group rhinovirus receptor, P3.58) |
|||
| MBS637697-001mg | MyBiosource | 0.01mg | EUR 555 |
CD54, Recombinant, Human (ICAM-1, Intercellular Adhesion Molecule1, Human rhinovirus receptor, Precursor, BB2, Major group rhinovirus receptor, P3.58) |
|||
| MBS637697-5x001mg | MyBiosource | 5x0.01mg | EUR 2340 |
 Recombinant Human rhinovirus A serotype 89 Genome polyprotein |
|||
| MBS9422687-002mg | MyBiosource | 0.02mg | EUR 320 |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein |
|||
| MBS9422687-01mg | MyBiosource | 0.1mg | EUR 540 |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein |
|||
| MBS9422687-05mg | MyBiosource | 0.5mg | EUR 1360 |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein |
|||
| MBS9422687-5x05mg | MyBiosource | 5x0.5mg | EUR 5965 |
 Recombinant Human rhinovirus A serotype 89 Genome polyprotein VP1 |
|||
| MBS1245807-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 255 |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein VP1 |
|||
| MBS1245807-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 270 |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein VP1 |
|||
| MBS1245807-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 405 |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein VP1 |
|||
| MBS1245807-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 450 |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein VP1 |
|||
| MBS1245807-05mgYeast | MyBiosource | 0.5mg(Yeast) | EUR 1065 |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein VP1 |
|||
| MBS9421040-002mg | MyBiosource | 0.02mg | EUR 285 |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein VP1 |
|||
| MBS9421040-01mg | MyBiosource | 0.1mg | EUR 470 |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein VP1 |
|||
| MBS9421040-1mg | MyBiosource | 1mg | EUR 1785 |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein VP1 |
|||
| MBS9421040-5x1mg | MyBiosource | 5x1mg | EUR 7885 |
 Rhinovirus Type 1A Lysate |
|||
| NAT41626-100 | The Native Antigen Company | 0.1 | EUR 512.85 |
|
Description: Rhinovirus consists of a non-enveloped capsid containing a positive-sense single-stranded RNA. |
|||
Rhinovirus Type 1A Lysate |
|||
| NAT41626-500 | The Native Antigen Company | 0.5 | EUR 2181.53 |
|
Description: Rhinovirus consists of a non-enveloped capsid containing a positive-sense single-stranded RNA. |
|||
 Recombinant Human rhinovirus A serotype 89 Genome polyprotein, partial |
|||
| CSB-YP362073HQD | Cusabio | 6387 mg | Ask for price |
 Recombinant Human rhinovirus A serotype 89 Genome polyprotein,partial |
|||
| AP71163 | SAB | 1mg | EUR 1978 |
|
|||
Recombinant Human rhinovirus A serotype 89 Genome polyprotein,partial |
|||
| AP72984 | SAB | each | Ask for price |
|
|||
Recombinant Human rhinovirus A serotype 89 Genome polyprotein,partial |
|||
| AP77542 | SAB | 1mg | EUR 1978 |
|
|||
Recombinant Human rhinovirus A serotype 89 Genome polyprotein, partial |
|||
| CSB-EP362073HQD | Cusabio | 3389 mg | Ask for price |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein, partial |
|||
| CSB-EP362073HQDb0 | Cusabio | 3390 mg | Ask for price |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein,partial |
|||
| RPC22779-100ug | Biomatik Corporation | 100ug | EUR 460.9 |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein,partial |
|||
| RPC22779-1mg | Biomatik Corporation | 1mg | EUR 2237.8 |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein,partial |
|||
| RPC22779-20ug | Biomatik Corporation | 20ug | EUR 258.7 |
 (1 mL)) NATtrol Human Rhinovirus Type 1A Stock(Qualitative) (1 mL) |
|||
| NATHRV-STN | Zeptometrix | 1 mL | EUR 1281 |
 Recombinant Human rhinovirus A serotype 89 Genome polyprotein, partial, Biotinylated |
|||
| CSB-EP362073HQD-B | Cusabio | 7058 mg | Ask for price |
 Recombinant Human rhinovirus A serotype 89 Genome polyprotein,partial,Biotinylated |
|||
| RPC27677-100ug | Biomatik Corporation | 100ug | EUR 614.3 |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein,partial,Biotinylated |
|||
| RPC27677-1mg | Biomatik Corporation | 1mg | EUR 2373.6 |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein,partial,Biotinylated |
|||
| RPC27677-20ug | Biomatik Corporation | 20ug | EUR 468 |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein, partial, Biotinylated |
|||
| MBS7137014-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 255 |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein, partial, Biotinylated |
|||
| MBS7137014-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 405 |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein, partial, Biotinylated |
|||
| MBS7137014-1mgEColi | MyBiosource | 1mg(E-Coli) | EUR 1425 |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein, partial, Biotinylated |
|||
| MBS7137014-5x1mgEColi | MyBiosource | 5x1mg(E-Coli) | EUR 6215 |
 ELISA Kit) Human Rhinovirus(RV) ELISA Kit |
|||
| SL3210Hu | Sunlong | 96 Tests | EUR 468 |
|
|||
 Human Rhinovirus,Rhv ELISA Kit |
|||
| YLA2915HU-48T | Shanghai YL Biotech | 48T | Ask for price |
Human Rhinovirus,Rhv ELISA Kit |
|||
| YLA2915HU-96T | Shanghai YL Biotech | 96T | Ask for price |
 Human Rhinovirus,Rhv ELISA KIT |
|||
| ED0457Hu | Jiaxing Korain Biotech Ltd (BT Labs) | 96 wells | EUR 458 |
ELISA Kit) Human Rhinovirus(Rhv)ELISA Kit |
|||
| QY-E04146 | Qayee Biotechnology | 96T | EUR 433.2 |
 Human Rhinovirus IgG ELISA Kit |
|||
| abx055879-100g | Abbexa | 100 µg | Ask for price |
Human Rhinovirus IgG ELISA Kit |
|||
| abx055879-10g | Abbexa | 10 µg | EUR 493.75 |
Human Rhinovirus IgG ELISA Kit |
|||
| abx055879-50g | Abbexa | 50 µg | Ask for price |
 Human Rhinovirus, Rhv ELISA Kit |
|||
| MBS1610750-10x96StripWells | MyBiosource | 10x96-Strip-Wells | EUR 3460 |
Human Rhinovirus, Rhv ELISA Kit |
|||
| MBS1610750-5x96StripWells | MyBiosource | 5x96-Strip-Wells | EUR 1750 |
Human Rhinovirus, Rhv ELISA Kit |
|||
| MBS1610750-96StripWells | MyBiosource | 96-Strip-Wells | EUR 425 |
Genetic analysis of persistency indices of milk yield in Jersey crossbred cattle
The study reported in this Research Communication was conducted to estimate genetic parameters for different lactation persistency indices and their association with reproductive traits in Jersey crossbred cattle. Data on lactation traits (part lactation yields and 305-days milk yield) comprising all lactations as well as reproductive traits viz. calving interval, conception rate and gestation length of 378 Jersey crossbred cattle, maintained at National Dairy Research Institute, Kalyani, West Bengal, India, were collected over a period of 35 years (1982-2016).
Five lactation persistency indices of animals (P21, P31, P32, P4 and P5) were calculated using ratio method. A total of six different animal models, ignoring or including maternal genetic or permanent environmental effects, were fitted for all persistency traits. The best model was chosen after testing the improvement of the log-likelihood values.
The estimates of direct heritability were low in magnitude and ranged from 0.02 to 0.14 for the studied traits under the best fitted animal model. The permanent maternal environmental (c2) effects of different lactation persistency indices accounted for 2-9% of the total phenotypic variance in this study. Estimated genetic correlations of lactation persistency indices with all studied reproductive traits were low to moderate and negative (-0.11 to -0.68), except for calving interval.
Phenotypic correlations of lactation persistency measures with studied reproductive traits were low (0.01 to 0.15). The low heritability estimates of all the persistency indices indicate some limited scope of genetic improvement of lactation persistency of animals through selection under the prevailing management conditions.
Genome Wide Analysis of the Transcriptional Profiles in Different Regions of the Developing Rice Grains
Background: Rice is an important food source for humans worldwide. Because of its nutritional and agricultural significance, a number of studies addressed various aspects of rice grain development and grain filling. Nevertheless, the molecular processes underlying grain filling and development, and in particular the contributions of different grain tissues to these processes, are not understood.
Main text: Using RNA-sequencing, we profiled gene expression activity in grain tissues comprised of cross cells (CC), the nucellar epidermis (NE), ovular vascular trace (OVT), endosperm (EN) and the aleurone layer (AL). These tissues were dissected using laser capture microdissection (LCM) at three distinct grain development stages. The mRNA expression datasets offer comprehensive and new insights into the gene expression patterns in different rice grain tissues and their contributions to grain development.
Comparative analysis of the different tissues revealed their similar and/or unique functions, as well as the spatio-temporal regulation of common and tissue-specific genes. The expression patterns of genes encoding hormones and transporters indicate an important role of the OVT tissue in metabolite transport during grain development. Gene co-expression network prediction on OVT-specific genes identified several distinct and common development-specific transcription factors. Further analysis of enriched DNA sequence motifs proximal to OVT-specific genes revealed known and novel DNA sequence motifs relevant to rice grain development.
Conclusion: Together, the dataset of gene expression in rice grain tissues is a novel and useful resource for further work to dissect the molecular and metabolic processes during rice grain development.
) Recombinant Human AITRL (AITRL Human) |
|||
| MBS555501-0005mg | MyBiosource | 0.005mg | EUR 220 |
Recombinant Human AITRL (AITRL Human) |
|||
| MBS555501-002mg | MyBiosource | 0.02mg | EUR 320 |
Recombinant Human AITRL (AITRL Human) |
|||
| MBS555501-5x002mg | MyBiosource | 5x0.02mg | EUR 1300 |
) TWEAK, recombinant / TNFSF12, recombinant (Human) |
|||
| 054-85 | PHOENIX PEPTIDE | 10 μg | EUR 261.36 |
 Recombinant Human PGⅡ |
|||
| E21-RA29-1 | EnoGene | - | Ask for price |
 Recombinant Human GC |
|||
| MBS7616369-005mg | MyBiosource | 0.05mg | EUR 405 |
Recombinant Human GC |
|||
| MBS7616369-02mg | MyBiosource | 0.2mg | EUR 760 |
Recombinant Human GC |
|||
| MBS7616369-1mg | MyBiosource | 1mg | EUR 2175 |
Recombinant Human GC |
|||
| MBS7616369-5x1mg | MyBiosource | 5x1mg | EUR 8410 |
 Recombinant Human GH |
|||
| MBS7608417-005mg | MyBiosource | 0.05mg | EUR 405 |
Recombinant Human GH |
|||
| MBS7608417-02mg | MyBiosource | 0.2mg | EUR 760 |
Recombinant Human GH |
|||
| MBS7608417-1mg | MyBiosource | 1mg | EUR 2175 |
Recombinant Human GH |
|||
| MBS7608417-5x1mg | MyBiosource | 5x1mg | EUR 8410 |
 Recombinant Human GS |
|||
| MBS7608504-005mg | MyBiosource | 0.05mg | EUR 345 |
Recombinant Human GS |
|||
| MBS7608504-02mg | MyBiosource | 0.2mg | EUR 635 |
Recombinant Human GS |
|||
| MBS7608504-1mg | MyBiosource | 1mg | EUR 1800 |
Recombinant Human GS |
|||
| MBS7608504-5x1mg | MyBiosource | 5x1mg | EUR 6955 |
 Recombinant Human C6 |
|||
| MBS7608602-005mg | MyBiosource | 0.05mg | EUR 345 |
Recombinant Human C6 |
|||
| MBS7608602-02mg | MyBiosource | 0.2mg | EUR 635 |
Recombinant Human C6 |
|||
| MBS7608602-1mg | MyBiosource | 1mg | EUR 1800 |
Recombinant Human C6 |
|||
| MBS7608602-5x1mg | MyBiosource | 5x1mg | EUR 6955 |
 Recombinant Human AR |
|||
| MBS7612815-005mg | MyBiosource | 0.05mg | EUR 405 |
Recombinant Human AR |
|||
| MBS7612815-02mg | MyBiosource | 0.2mg | EUR 760 |
Recombinant Human AR |
|||
| MBS7612815-1mg | MyBiosource | 1mg | EUR 2175 |
 Recombinant Human FH |
|||
| MBS7613325-005mg | MyBiosource | 0.05mg | EUR 405 |
Recombinant Human FH |
|||
| MBS7613325-02mg | MyBiosource | 0.2mg | EUR 760 |
Recombinant Human FH |
|||
| MBS7613325-1mg | MyBiosource | 1mg | EUR 2175 |
Recombinant Human FH |
|||
| MBS7613325-5x1mg | MyBiosource | 5x1mg | EUR 8410 |
 Recombinant Human HP |
|||
| MBS7614251-005mg | MyBiosource | 0.05mg | EUR 405 |
Recombinant Human HP |
|||
| MBS7614251-02mg | MyBiosource | 0.2mg | EUR 760 |
Recombinant Human HP |
|||
| MBS7614251-1mg | MyBiosource | 1mg | EUR 2175 |
Recombinant Human HP |
|||
| MBS7614251-5x1mg | MyBiosource | 5x1mg | EUR 8410 |
Recombinant Human AR |
|||
| MBS7612815-5x1mg | MyBiosource | 5x1mg | EUR 8410 |
 Recombinant Human CP |
|||
| MBS7613562-005mg | MyBiosource | 0.05mg | EUR 405 |
Recombinant Human CP |
|||
| MBS7613562-02mg | MyBiosource | 0.2mg | EUR 760 |
Recombinant Human CP |
|||
| MBS7613562-1mg | MyBiosource | 1mg | EUR 2175 |
Recombinant Human CP |
|||
| MBS7613562-5x1mg | MyBiosource | 5x1mg | EUR 8410 |
 Recombinant Human TH |
|||
| MBS7613924-005mg | MyBiosource | 0.05mg | EUR 345 |
Recombinant Human TH |
|||
| MBS7613924-02mg | MyBiosource | 0.2mg | EUR 635 |
Recombinant Human TH |
|||
| MBS7613924-1mg | MyBiosource | 1mg | EUR 1800 |
Recombinant Human TH |
|||
| MBS7613924-5x1mg | MyBiosource | 5x1mg | EUR 6955 |
 Recombinant Human C5 |
|||
| MBS7609068-005mg | MyBiosource | 0.05mg | EUR 345 |
Recombinant Human C5 |
|||
| MBS7609068-02mg | MyBiosource | 0.2mg | EUR 635 |
Recombinant Human C5 |
|||
| MBS7609068-1mg | MyBiosource | 1mg | EUR 1800 |
Recombinant Human C5 |
|||
| MBS7609068-5x1mg | MyBiosource | 5x1mg | EUR 6955 |
 Recombinant Human Rb |
|||
| MBS7609212-005mg | MyBiosource | 0.05mg | EUR 470 |
Recombinant Human Rb |
|||
| MBS7609212-02mg | MyBiosource | 0.2mg | EUR 885 |
Recombinant Human Rb |
|||
| MBS7609212-1mg | MyBiosource | 1mg | EUR 2540 |
Recombinant Human Rb |
|||
| MBS7609212-5x1mg | MyBiosource | 5x1mg | EUR 9820 |
Recombinant Human FH |
|||
| MBS7609262-005mg | MyBiosource | 0.05mg | EUR 560 |
Recombinant Human FH |
|||
| MBS7609262-02mg | MyBiosource | 0.2mg | EUR 1060 |
Recombinant Human FH |
|||
| MBS7609262-1mg | MyBiosource | 1mg | EUR 3065 |
Recombinant Human FH |
|||
| MBS7609262-5x1mg | MyBiosource | 5x1mg | EUR 11850 |
 Recombinant Human C4 |
|||
| MBS7609327-005mg | MyBiosource | 0.05mg | EUR 405 |
Recombinant Human C4 |
|||
| MBS7609327-02mg | MyBiosource | 0.2mg | EUR 760 |
Recombinant Human C4 |
|||
| MBS7609327-1mg | MyBiosource | 1mg | EUR 2175 |
Recombinant Human C4 |
|||
| MBS7609327-5x1mg | MyBiosource | 5x1mg | EUR 8410 |
Recombinant Human C4 |
|||
| MBS7609328-005mg | MyBiosource | 0.05mg | EUR 405 |
Recombinant Human C4 |
|||
| MBS7609328-02mg | MyBiosource | 0.2mg | EUR 760 |
Recombinant Human C4 |
|||
| MBS7609328-1mg | MyBiosource | 1mg | EUR 2175 |
Recombinant Human C4 |
|||
| MBS7609328-5x1mg | MyBiosource | 5x1mg | EUR 8410 |
Recombinant Human GH |
|||
| P1223-.1 | ApexBio | 10X10ug | EUR 240 |
|
Description: Peptides & Proteins|Recombinant Proteins |
|||
Recombinant Human GH |
|||
| P1223-.5 | ApexBio | 50X10ug | EUR 538.4 |
|
Description: Peptides & Proteins|Recombinant Proteins |
|||
:Fc (human), (recombinant)) DR3 (human):Fc (human), (recombinant) |
|||
| MBS566215-005mg | MyBiosource | 0.05mg | EUR 585 |
DR3 (human):Fc (human), (recombinant) |
|||
| MBS566215-5x005mg | MyBiosource | 5x0.05mg | EUR 2585 |
 Recombinant Human REC8 |
|||
| MBS7613173-005mg | MyBiosource | 0.05mg | EUR 405 |
Recombinant Human REC8 |
|||
| MBS7613173-02mg | MyBiosource | 0.2mg | EUR 760 |
Recombinant Human REC8 |
|||
| MBS7613173-1mg | MyBiosource | 1mg | EUR 2175 |
Recombinant Human REC8 |
|||
| MBS7613173-5x1mg | MyBiosource | 5x1mg | EUR 8410 |
 Recombinant Human PRL |
|||
| AP76222 | SAB | 1mg | EUR 2369 |
|
|||
Recombinant Human PRL |
|||
| CM10-10ug | Novoprotein | 10ug | EUR 169.2 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
|||
Recombinant Human PRL |
|||
| CM10-1mg | Novoprotein | 1mg | EUR 2008.8 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
|||
Recombinant Human PRL |
|||
| CM10-500ug | Novoprotein | 500ug | EUR 1423.2 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
|||
Recombinant Human PRL |
|||
| CM10-50ug | Novoprotein | 50ug | EUR 363.6 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
|||
 Recombinant Human BAD |
|||
| 7-04501 | CHI Scientific | 2µg | Ask for price |
Recombinant Human BAD |
|||
| 7-04502 | CHI Scientific | 5µg | Ask for price |
Recombinant Human BAD |
|||
| 7-04503 | CHI Scientific | 10µg | Ask for price |
 Recombinant Human CD2 |
|||
| 7-04717 | CHI Scientific | 2µg | Ask for price |
Recombinant Human CD2 |
|||
| 7-04718 | CHI Scientific | 5µg | Ask for price |
Recombinant Human CD2 |
|||
| 7-04719 | CHI Scientific | 10µg | Ask for price |
 Recombinant Human CD9 |
|||
| 7-04741 | CHI Scientific | 2µg | Ask for price |
Recombinant Human CD9 |
|||
| 7-04742 | CHI Scientific | 5µg | Ask for price |
Recombinant Human CD9 |
|||
| 7-04743 | CHI Scientific | 10µg | Ask for price |
 Recombinant Human p53 |
|||
| 7-05785 | CHI Scientific | 2µg | Ask for price |
Recombinant Human p53 |
|||
| 7-05786 | CHI Scientific | 5µg | Ask for price |
Recombinant Human p53 |
|||
| 7-05787 | CHI Scientific | 10µg | Ask for price |
 Recombinant Human CSK |
|||
| Z500098 | ABM | 10 µg | EUR 370 |
|
Description: CSK is a cytoplasmic tyrosine kinase that has been shown to downregulate the tyrosine kinase activity of the c-src through tyrosine phosphorylation of the c-src carboxy terminus . A yeast 2-hybrid system has been used to identify proteins associated with CSK. The Src homology-3 (SH3) domain of CSK associates with a proline-rich region of PEP, a protein-tyrosine phosphatase expressed in hemopoietic cells . This association is highly specific and it is speculated that PEP may be an effector and/or regulator of CSK in T cells and other hemopoietic cells. |
|||